Outer membrane protein P6 of nontypeable Haemophilus influenzae is a potent and selective inducer of human macrophage proinflammatory cytokines
- PMID: 15845475
- PMCID: PMC1087348
- DOI: 10.1128/IAI.73.5.2728-2735.2005
Outer membrane protein P6 of nontypeable Haemophilus influenzae is a potent and selective inducer of human macrophage proinflammatory cytokines
Abstract
Interactions of nontypeable Haemophilus influenzae (NTHI) with human macrophages contribute to the pathogenesis of NTHI-induced infection in humans. However, the immunologic mechanisms that initiate and perpetuate NTHI-mediated macrophage responses have not been well explored. Outer membrane protein (OMP) P6 is a conserved lipoprotein expressed by NTHI in vivo that possesses a Pam(3)Cys terminal motif, characteristic of immunoactive bacterial lipoproteins associated with Toll-like receptor signaling. We theorized that OMP P6 is a potent immunomodulator of human macrophages. To test this hypothesis, we purified OMP P6 as well as OMP P2, the predominant NTHI outer membrane protein, and lipooligosaccharide (LOS), the specific endotoxin of NTHI, from NTHI strain 1479. Human blood monocyte-derived macrophages, purified from healthy donors, were incubated with each outer membrane constituent, and cytokine production of macrophage supernatants interleukin-1beta (IL-1beta), tumor necrosis factor alpha (TNF-alpha), IL-10, IL-12, and IL-8 was measured. OMP P6 selectively upregulated IL-10, TNF-alpha, and IL-8. While OMP P6 (0.1 mug/ml for 8 h) elicited slightly greater concentrations of IL-10, it resulted in over ninefold greater concentrations of TNF-alpha and over fourfold greater concentrations of IL-8 than did OMP P2. OMP P6 at doses as low as 10 pg/ml was still effective at induction of macrophage IL-8, while OMP P2 and LOS were not. OMP P6 of NTHI is a specific trigger of bacteria-induced human macrophage inflammatory events, with IL-8 and TNF-alpha as key effectors of P6-induced macrophage responses.
Figures







Similar articles
-
Impaired alveolar macrophage response to Haemophilus antigens in chronic obstructive lung disease.Am J Respir Crit Care Med. 2006 Jul 1;174(1):31-40. doi: 10.1164/rccm.200509-1461OC. Epub 2006 Mar 30. Am J Respir Crit Care Med. 2006. PMID: 16574934 Free PMC article.
-
Conserved nontypeable Haemophilus influenzae-derived TLR2-binding lipopeptides synergize with IFN-beta to increase cytokine production by resident murine and human alveolar macrophages.J Immunol. 2006 Jul 1;177(1):673-80. doi: 10.4049/jimmunol.177.1.673. J Immunol. 2006. PMID: 16785566 Free PMC article.
-
Th17 cells contribute to nontypeable Haemophilus influenzae-specific protective immunity induced by nasal vaccination with P6 outer membrane protein and α-galactosylceramide.Microbiol Immunol. 2011 Aug;55(8):574-81. doi: 10.1111/j.1348-0421.2011.00352.x. Microbiol Immunol. 2011. PMID: 21605159
-
Developing a nontypeable Haemophilus influenzae (NTHi) vaccine.Vaccine. 2000 Dec 8;19 Suppl 1:S108-15. doi: 10.1016/s0264-410x(00)00288-7. Vaccine. 2000. PMID: 11163473 Review.
-
Studies on P6, an important outer-membrane protein antigen of Haemophilus influenzae.Rev Infect Dis. 1988 Jul-Aug;10 Suppl 2:S331-6. doi: 10.1093/cid/10.supplement_2.s331. Rev Infect Dis. 1988. PMID: 3055201 Review.
Cited by
-
Vaccines for Nontypeable Haemophilus influenzae: the Future Is Now.Clin Vaccine Immunol. 2015 May;22(5):459-66. doi: 10.1128/CVI.00089-15. Epub 2015 Mar 18. Clin Vaccine Immunol. 2015. PMID: 25787137 Free PMC article. Review.
-
Specific IgA and metalloproteinase activity in bronchial secretions from stable chronic obstructive pulmonary disease patients colonized by Haemophilus influenzae.Respir Res. 2012 Dec 11;13(1):113. doi: 10.1186/1465-9921-13-113. Respir Res. 2012. PMID: 23228114 Free PMC article.
-
Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease.Am J Respir Crit Care Med. 2006 May 1;173(9):991-8. doi: 10.1164/rccm.200509-1525OC. Epub 2006 Feb 10. Am J Respir Crit Care Med. 2006. PMID: 16474030 Free PMC article.
-
Non-typeable Haemophilus influenzae major outer membrane protein P5 contributes to bacterial membrane stability, and affects the membrane protein composition crucial for interactions with the human host.Front Cell Infect Microbiol. 2023 May 26;13:1085908. doi: 10.3389/fcimb.2023.1085908. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37305414 Free PMC article.
-
A biphasic epigenetic switch controls immunoevasion, virulence and niche adaptation in non-typeable Haemophilus influenzae.Nat Commun. 2015 Jul 28;6:7828. doi: 10.1038/ncomms8828. Nat Commun. 2015. PMID: 26215614 Free PMC article.
References
-
- Abe, Y., T. F. Murphy, S. Sethi, H. S. Faden, J. Dmochowski, Y. Harabuchi, and Y. M. Thanavala. 2002. Lymphocyte proliferative response to P6 of Haemophilus influenzae is associated with relative protection from exacerbations of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 165:967-971. - PubMed
-
- Aliprantis, A. O., R. B. Yang, M. R. Mark, S. Suggett, B. Devaux, J. D. Radolf, G. R. Klimpel, P. Godowski, and A. Zychlinsky. 1999. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 285:736-739. - PubMed
-
- Badr, W. H., D. Loghmanee, R. J. Karalus, T. F. Murphy, and Y. Thanavala. 1999. Immunization of mice with P6 of nontypeable Haemophilus influenzae: kinetics of the antibody response and IgG subclasses. Vaccine 18:29-37. - PubMed
-
- Berenson, C. S., M. A. Gallery, J. M. Smigiera, and R. H. Rasp. 2002. The role of ceramide of human macrophage gangliosides in activation of human macrophages. J. Leukoc. Biol. 72:492-502. - PubMed
-
- Berenson, C. S., M. A. Patterson, M. A. Pattoli, and T. F. Murphy. 1996. A monoclonal antibody to human macrophage gangliosides inhibits macrophage migration. J. Leukoc. Biol. 59:371-379. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous